References
- Ridley MG, Kingsley G, Pitzalis C, Panayi GS. Monocyte activation in rheumatoid arthritis: evidence for in situ activation and differentiation in joints. Br J Rheumatol. 1990;29:84–8.
- Joosten LA, Helsen MM, Saxne T, et al. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type 2 collagen- induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation. J Immunol. 1999;163:5049–55.
- Eliott MJ, Maini RN, Feldmann M, et al. Randomised double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha(ca2) versus placebo in rheumatoid arthritis. Lancet. 1994;344:1105–10.
- Bliddal H, Terslev L, Ovistgaard E, Kristoffersen H, Torp-Pedersen S, Danneskiold-Samsoe B. Injection of etanercept into arthritic joints. 1. Safety. Ann Rheum Dis. 2002;61\(Suppl 1):169.
- Bliddal H, Ovistgaard E, Terslev L, Savnik A, Holm CC, Kristoffersen H, et al. Injection of etanercept into arthritic joints. 2. Dose-response and efficacy. Ann Rheum Dis. 2002;61\(Suppl 1):38.
- Arnold EL, Khanna D, Paulus H. Acute injection site reaction to intra-articular etanercept administration. Arthritis Rheum. 2003: 48(7):2078–9.
- Wang GJ, Sweet DE, Reger SI, Thompson RC. Fat-cell changes as a mechanism of avascular necrosis of the femoral head in cortisone-treated rabbits. J Bone Joint Surg Am. 1977;59:729–35
- Goldring SR, Goldring MB. Cytokines and skeletal physiology. Clin Orthop. 1996;324:13–23.
- Goldring SR, Goldring MB. Prospects for pharmacological intervention. In: Gowen M (ed) Cytokines and bone metabolism. CRC Press, Boca Raton 1996, pp 383–406.